THE PATHOBIOLOGY OF PULMONARY HYPERTENSION: Endothelium
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 22 (3) , 405-418
- https://doi.org/10.1016/s0272-5231(05)70280-x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?Journal of Clinical Investigation, 2000
- A role for the serotonin transporter in hypoxia-induced pulmonary hypertensionJournal of Clinical Investigation, 2000
- Nitric oxide–an endothelial cell survival factorCell Death & Differentiation, 1999
- Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific MarkersThe American Journal of Pathology, 1999
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.Journal of Clinical Investigation, 1998
- Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.Journal of Clinical Investigation, 1997
- Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells.Journal of Clinical Investigation, 1997
- The role of vascular injury and hemodynamics in rat pulmonary artery remodeling.Journal of Clinical Investigation, 1996
- Coagulation and fibrinolytic parameters in patients with pulmonary hypertensionClinical Cardiology, 1996
- Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertensionEuropean Respiratory Journal, 1995